Here, we demonstrate that targeting neuronal expression of TFEB was sufficient to reduce synucleinopathy and prevent neurodegeneration in the A53T–α-syn rat model of PD, while only oligodendroglial overexpression of TFEB leads to neuroprotective effects in the MSA mouse model (Supplemental Figure 5). This evidence concerns the gene TFEB and Parkinson disease.